Hematology & Oncology Market Research Reports & Industry Analysis
Hematology & Oncology Industry Research & Market Reports
-
Global Ovarian Cancer Diagnostics Market - 2022-2029
... a CAGR of XX % during the forecast period (2022-2029). Ovarian cancer is the abnormal development of cells in the ovaries. The cells reproduce rapidly and can penetrate and destroy healthy body tissue. Patients with ... Read More
-
Imaging Agents Market Size, Share and Industry Analysis Report by Product Type (Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media), Application (Oncology, Gastrointestinal, Cardiology Neurology), Modality (X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound) and End-use (Hospitals, Ambulatory Surgical Centers, Diagnostic & Imaging Centers), Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
... Resonance Imaging (MRI), Ultrasound) and End-use (Hospitals, Ambulatory Surgical Centers, Diagnostic & Imaging Centers), Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030 The global imaging agents market is expected to register ... Read More
-
Oncology Information System Market Forecasts to 2028 – Global Analysis By Product & Services Software, Professional Services), Application (Medical Oncology, Radiation Oncology), End User (Government Institutions, Hospitals & Diagnostic Imaging Centers) and By Geography
... to Stratistics MRC, the Global Oncology Information System Market is accounted for $7.46 billion in 2021 and is expected to reach $14.00 billion by 2028 growing at a CAGR of 9.4% during the forecast period. ... Read More
-
Molecular Diagnostics Market by Product & Service (Reagents, Kits, Instruments), Test Type (Lab, PoC), Technology (PCR, INAAT, NGS, ISH), Application (Infectious, Oncology, Genetic Testing), End User (Diagnostic Labs, Hospitals) - Global Forecast to 2027
... global molecular diagnostics market is projected to reach USD 30.2 billion by 2027 from USD 23.2 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such ... Read More
-
Middle East and Asia Pacific Antibody Drugs Market, by Type (Monoclonal Antibodies, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody), by Disease Indication (Oncology, Neurology, Autoimmune D
... Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Middle East (Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, Turkey, Qatar, and Rest of Middle East) and Asia Pacific (South East Asia, The ... Read More
-
In-vitro Diagnostics Market - by Product Type (Instruments and Reagents & Kits), by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Urinalysis, and Others), by Application (Infectious
... Autoimmune Disorders, and Others), by End User (Hospital, Pathology Laboratories, Point-of-Care Diagnostics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and ... Read More
-
Global Cancer Diagnostics Market Size study, by Diagnostic Type (Diagnostic Imaging, Tests, Biopsy and Cytology Tests, Tumour Biomarkers and Other Diagnostic Types) by Application (Breast Cancer, Lung Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer and Other Applications) and Regional Forecasts 2022-2028
... Cancer, Ovarian Cancer and Other Applications) and Regional Forecasts 2022-2028 Global Cancer Diagnostics Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more ... Read More
-
2022 Global Forecast for Immuno Oncology Assays (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
2022 Global Forecast for Cancer Diagnostics (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size By Technology (Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Nucleic Acid Sequence-based Amplification (NASBA), Helicase-dependent Amplification (HDA)), By Product (Instruments, Reagents), By Application, (Infectious Disease {HIV, Influenza, Malaria, Tuberculosis}, Oncology, Blood Screening), By End-use (Hospitals, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028
... Influenza, Malaria, Tuberculosis}, Oncology, Blood Screening), By End-use (Hospitals, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028 The isothermal nucleic acid amplification technology ... Read More
-
2022 Global Forecast for Tissue Diagnostics (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
2022 Global Forecast for Women'S Health Care (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Asia Cervical Cancer Test (Screening) Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19
... cancer caused due to the rampant proliferation of the cell. In 2021, as per our Report Statistics, more than 100 Million populations were diagnosed with cervical cancer. In women, cervical cancer ranks as the 4th ... Read More
-
Asia-Pacific Oncology Market Databank
... segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated ... Read More
-
Latin America, Middle East & Africa Oncology Market Databank
... 2021 to 2029. Cancer treatment segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. ... Read More
-
North America Oncology Market Databank
... treatment segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is ... Read More
-
Global Oncology Market Databank
... segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated ... Read More
-
Leading Oncology Cancer Type Markets Databank
... Breast cancer segment is expected to be the highest contributor to this market, with $60,659.5 Million in 2020, and is anticipated to reach $88,239.8 Million by 2029, registering a CAGR of 4.30%. Colon & rectal ... Read More
-
Europe Oncology Market Databank
... segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated ... Read More
-
Leading Oncology Country Markets Databank
... is expected to be the highest contributor to this market, with $94,840.8 Million in 2020, and is anticipated to reach $162,447.5 Million by 2029, registering a CAGR of 6.20%. Asia-Pacific and Europe collectively expected to ... Read More
-
Leading Oncology By Cancer Diagnostics & Treatment Markets Databank
... 2021 to 2029. Cancer treatment segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. ... Read More
-
IVD Contract Research Organization Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Clinical Chemistry, Molecular Diagnostics, Immunochemistry, Companion Diagnostics, Hematology, Histology & Cytology, Microbiology, and Others), Services (Clinical Research, Biostatistics & Data Management Services, Therapeutic Expertise, Regulatory Services, Reimbursement Support Services, Assay Development Services, and Others), and Geography
... Data Management Services, Therapeutic Expertise, Regulatory Services, Reimbursement Support Services, Assay Development Services, and Others), and Geography The global IVD contract research organization market is expected to grow from US$ 4,738.79 million in 2021 to ... Read More
-
Next-Generation Gynecological Cancer Diagnostics Market - A Global Market and Regional Analysis: Focus on Technology, Product Type, End User, and Country Analysis - Analysis and Forecast, 2020-2031
... Market Segmentation By Product Type - Products and Services By Technology - Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others By Indication - Ovarian Cancer, Cervical Cancer, and Uterine Cancer By End User - ... Read More
-
Oncology Nutrition Market
... important market dynamics. After conducting thorough research on the historical and current growth parameters of the Oncology Nutrition Market, the growth prospects of the market are obtained with maximum precision. Market Segmentation The Oncology Nutrition ... Read More
-
Global Next-Generation Cancer Diagnostics Market 2022-2028
... of death partly reflects marked declines in mortality rates of stroke and coronary heart disease, relative to cancer, in many countries. Next-generation cancer diagnostics aim to promote prevention and early detection of cancer. Garnering a ... Read More
Research Assistance
